Surgalign Holdings, Inc.

OTCPK:SRGA.Q Stock Report

Market Cap: US$165.3k

Surgalign Holdings Past Earnings Performance

Past criteria checks 0/6

Surgalign Holdings's earnings have been declining at an average annual rate of -9.6%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 27.9% per year.

Key information

-9.6%

Earnings growth rate

0.08%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-27.9%
Return on equityn/a
Net Margin-64.6%
Last Earnings Update31 Mar 2023

Recent past performance updates

Recent updates

Surgalign stock rises 7% after receiving FDA clearance of Cortera spinal fixation system

Aug 24

Surgalign revenue of $20.62M misses by $0.51M, reconfirms full-year revenue

Aug 09

Surgalign Holdings - A Future Of Digital Surgery

Dec 21

Sizing Up Surgalign

Sep 23

Surgalign Holdings: Insiders Are Buying

Aug 28

Surgalign Holdings: Pinocchio Has A Happy Ending

Aug 10

Surgalign Holdings: A Marketing Ploy

Jun 29

Surgalign reports inducement grants under Nasdaq listing rule

Jun 04

Have Insiders Been Buying Surgalign Holdings, Inc. (NASDAQ:SRGA) Shares?

Mar 08
Have Insiders Been Buying Surgalign Holdings, Inc. (NASDAQ:SRGA) Shares?

Surgalign Holdings : Strong Upside Potential

Jan 11

Revenue & Expenses Breakdown

How Surgalign Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:SRGA.Q Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2378-509214
31 Dec 2282-559616
30 Sep 2283-629917
30 Jun 2284-6110316
31 Mar 2288-6610415
31 Dec 2191-8110414
30 Sep 2195-15210711
30 Jun 21102-17110710
31 Mar 2198-18511311
31 Dec 20102-19412412
30 Sep 20107-27513714
30 Jun 20108-26614416
31 Mar 2075-26414017
31 Dec 19117-24913517
30 Sep 19157-4912817
30 Jun 19197-2912316
31 Mar 19280-1312315
31 Dec 1892-529814
30 Sep 18280-1411613
30 Jun 18278011413
31 Mar 18280311413
31 Dec 17280311513
30 Sep 17280-111614
30 Jun 17280-2211715
31 Mar 17275-2211816
31 Dec 16276-1711716
30 Sep 16278-311516
30 Jun 16278411116
31 Mar 162821010816
31 Dec 152821210715
30 Sep 15277810816
30 Jun 15276710916
31 Mar 15270610915
31 Dec 14263010816
30 Sep 14252-910515
30 Jun 14242-1910316
31 Mar 14218-249116
31 Dec 13198-198215
30 Sep 13182-87114
30 Jun 1317246013
31 Mar 1317585913
31 Dec 1217885812

Quality Earnings: SRGA.Q is currently unprofitable.

Growing Profit Margin: SRGA.Q is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SRGA.Q is unprofitable, and losses have increased over the past 5 years at a rate of 9.6% per year.

Accelerating Growth: Unable to compare SRGA.Q's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SRGA.Q is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).


Return on Equity

High ROE: SRGA.Q's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies